SCHEMBL29329930

SCHEMBL29329930

CCC[C@H](CC(=O)NCCCCCCCCCCCCCCCCCC(=O)O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 9/20 0.51
PLA2G2A P14555 1/20 0.49
ADRA1A P35348 2/20 0.49
FOLH1 Q04609 1/20 0.47
PRMT1 Q99873 1/20 0.47
PLA2G4A P47712 1/20 0.45
ALDH1A1 P00352 2/20 0.45
CASP2 P42575 1/20 0.45
KDM4E B2RXH2 1/20 0.45
CHRM1 P11229 1/20 0.44
AKR1A1 P14550 1/20 0.44
CHRM3 P20309 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12886460 0.88 NAAA (0.49) ADRA1AFOLH1CASP2CHRM1AKR1A1
SCHEMBL11413744 0.83 CASP2 (0.53) CASP2GPR84
SCHEMBL12830741 0.83 CASP2 (0.53) CASP2GPR84
SCHEMBL14490616 0.81 ADRA1A (0.55) EPHX2PLA2G2AADRA1APRMT1PLA2G4A
SCHEMBL1376162 0.80 FOLH1 (0.61) FOLH1
SCHEMBL9646260 0.80 CASP2 (0.53) EPHX2PLA2G2ACASP2
SCHEMBL13133093 0.79 EPHX2 (0.56) EPHX2PLA2G2AADRA1APRMT1ALDH1A1
SCHEMBL25651300 0.79 KMT2A (0.55) ADRA1AFOLH1ALDH1A1CHRM1AKR1A1
Stearic Acid SCHEMBL6298635 0.78 EPHX2 (0.61) EPHX2PLA2G2APLA2G4ACASP2KDM4E
SCHEMBL24711402 0.77 ADRA1A (0.58) EPHX2PLA2G2AADRA1APRMT1PLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239859-A1 Long-Acting GLP-1 Compound GAN & LEE PHARMACEUTICALS CO., LTD. (CN) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239859-A1 Long-Acting GLP-1 Compound GLP1R, GIPR, DPP4 EPHX2 4568/4885PLA2G2A 3183/4885ADRA1A 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.